Specimen Banking From Patients With Lung Cancer
The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.
Checked against the public recordLast updated Jan 29, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- University of Colorado, Denver
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: 1. Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer. 2. Oral and written informed consent Exclusion Criteria: 1\. Any individual who does not give oral and written consent for participation
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Colorado Cancer CenterAurora, Colorado
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 29, 2026. Always confirm current availability with the study team.